Experimental depression induces renal oxidative stress in rats

Physiology and Behavior

Volumn 104, Issue 5, 2011, Pages 1002-1009

  Pedreañez, Adriana ^a   Arcaya, José Luis ^a   Carrizo, Edgardo ^a   Rincón, Jaimar ^a   Viera, Ninoska ^a   Peña, Caterina ^a   Vargas, Renata ^a   Mosquera, Jesús ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Angiotensin II; Depression; Kidney; Rats; Reactive oxygen species

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; GLUTATHIONE; LOSARTAN; MALONALDEHYDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SERTRALINE; SUPEROXIDE; WATER;

AEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FORCED SWIMMING TEST; HISTOLOGY; KIDNEY FUNCTION; KIDNEY METABOLISM; MACROPHAGE FUNCTION; MALE; MONOCYTE; MOTOR ACTIVITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; RENAL OXIDATIVE STRESS;

ANGIOTENSIN II; ANIMALS; DEPRESSION; DISEASE MODELS, ANIMAL; GLUTATHIONE; KIDNEY; MACROPHAGES; MALE; MALONDIALDEHYDE; MONOCYTES; MOTOR ACTIVITY; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES; SWIMMING; TIME FACTORS;

EID: 80053053037     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.06.021     Document Type: Article

References (61)

1. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neurol Endocrinol Lett 2008, 29:287-291.
2. Pedreañez A., Arcaya J.L., Carrizo E., Mosquera J. Forced swimming test increases superoxide anion positive cells and angiotensin II positive cells in the cerebrum and cerebellum of the rat. Brain Res Bull 2006, 71:18-22.
3. Sarandol A., Sarandol E., Eker S.S., Erdinc S., Vatansever E., Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007, 22:67-73.
4. Szuster-Ciesielska A., Słotwińska M., Stachura A., Marmurowska-Michałowska H., Dubas-Slemp H., Bojarska-Junak A. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:686-694.
5. Ng F., Berk M., Dean O., Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008, 11:851-876.
6. Selek S., Savas H.A., Gergerlioglu H.S., Bulbul F., Uz E., Yumru M. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 2008, 107:89-94.
7. Michel T.M., Frangou S., Thiemeyer D., Camara S., Jece J., Nara K. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder a postmortem study. Psychiatry Res 2007, 151:145-150.
8. Zafir A., Ara A., Banu N. In vivo antioxidant status: a putative target of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:220-228.
9. Mosovich S.A., Boone R.T., Reichenberg A., Bansilal S., Shaffer J., Dahlman K. New insights into the link between cardiovascular disease and depression. Int J Clin Pract 2008, 62:423-432.
10. Rago L., Kiivet R.A., Harro J., Pold M. Central- and peripheral-type benzodiazepine receptors: similar regulation by stress and GABA receptor agonists. Pharmacol Biochem Behav 1989, 32:879-883.
11. Burgin R., Weizman R., Gavish M. Repeated swim stress and peripheral-type benzodiazepine receptors. Neuropsychobiology 1996, 33:28-31.
12. Ratnakar S., Banupriya C., Doureradjou P., Vivekanandam S., Srivastava M.K., Koner B.C. Evaluation of anxiety, depression and urinary protein excretion among the family caregivers of advanced cancer patients. Biol Psychol 2008, 79:234-238.
13. Nakao C., Okawara T., Kizaki T., Oh-Ishi S., Miyazaki H., Haga S. Effects of swimming training on three superoxide dismutase isoenzymes in mouse tissues. J Appl Physiol 2000, 88:649-654.
14. Porsolt R.D., LePichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
15. Bilge S., Bozkurt A., Bas D.B., Aksoz E., Savli E., Ilkaya F., et al. Chronic treatment with fluoxetine and sertraline prevents forced swimming test-induced hypercontractility of rat detrusor muscle. Pharmacol Rep 2008, 60:872-879.
16. Bravo R., Somoza B., Ruiz-Gayo M., González C., Ruilope L.M., Fernández-Alfonso M.S. Differential effect of chronic antihypertensive treatment on vascular smooth muscle cell phenotype in spontaneously hypertensive rats. Hypertension 2001, 37:E4-E10.
17. Briggs R.T., Robinson J.M., Karnovsky M.L., Karnovsky M.J. Superoxide production by polymorphonuclear leukocytes. Histochemestry 1986, 84:371-378.
18. Green L.C., Wagner D.A., Glagowski J., Skipper P.L., Wishnok J.S., Tannenbaum G. Analysis of nitrate, nitrite and N nitrate in biological fluids. Anal Biochem 1982, 126:131-138.
19. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
20. Aebi H.E. Catalase. Methods of enzymatic analysis 1982, 271-282. Verlg Chemie, Weinheim, Germany. H.U. Bergmeyer (Ed.).
21. Beutler E., Duron O., Milkus B. Improved method for the determination of blood glutathione. J Lab Clin Med 1963, 16:882-888.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
23. Borsini F., Pulvirenti L., Samanin R. Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioral «dispairs» test in rats. Eur J Pharmacol 1985, 110:253-256.
24. Cervo L., Grignashi G., Samanin R. Differents effects of intracerebral and systemic administration of buspirone in the forced swimming test: involvement of a metabolite. Life Sci 1988, 43:2095-2102.
25. Kannan K., Jain S.K. Oxidative stress and apoptosis. Pathophysiology 2007, 153-163.
26. Halliwell B., Gutteridge J.M.C. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986, 246:501-514.
27. Root R.K., Metcalf J.A. Hydrogen peroxide release from human granulocytes during phagocytosis: relationship to superoxide anion formation and cellular catabolism of hydrogen peroxide: Studies with normal and cytochalasin B treated cells. J Clin Invest 1977, 60:1266-1279.
28. Aust S.D., Morehouse L.A., Thomas C.E. Role of metals in oxygen radicals reactions. J Free Radic Biol Med 1985, 1:23-25.
29. Shah S. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 1989, 35:1093-1106.
30. Ho Y., Magnenat J.L., Gargano M., Cao J. The nature of antioxidant defence mechanisms: a lesson from transgenic studies. Environ Health Persp 1998, 106:1219-1228.
31. Yen H., Oberley T., Vichitbandha S., Ho Y., St Clair D. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 1996, 98:1253-1260.
32. Terblanche S.E. The effects of exhaustive exercise on the activity levels of catalase in various tissues of male and female rats. Cell Biol Int 2000, 23:749-753.
33. Rincon J., Romero M., Viera N., Pedreanez A., Mosquera J. Increased oxidative stress and apoptosis in acute puromycin aminonucleoside nephrosis. Int J Exp Path 2004, 85:25-33.
34. Gomes P., Simão S., Silva E., Pinto V., Amaral J.S., Afonso J., et al. Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure. Oxid Med Cell Longev 2009, 2:138-145.
35. Zhao Z., Wang W., Guo H., Zhou D. Antidepressant-like effect of liquiritin from Glycyrrhiza uralensis in chronic variable stress induced depression model rats. Behav Brain Res 2008, 194:108-113.
36. Ghanizadeh A., Mansoori Y., Ashkani H., Fallahzadeh M.H., Derakhshan A., Shokrpour N., et al. Major depressive disorder in children and adolescents after renal transplantation. Transplant Proc 2009, 41:1627-1629.
37. Dobbels F., Skeans M.A., Snyder J.J., Tuomari A.V., Maclean J.R., Kasiske B.L. Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis 2008, 51:819-828.
38. Leeuwenburgh C., Ji L.L. Glutathione depletion in rested and exercised mice: biochemical consequence and adaptation. Arch Biochem Biophys 1995, 316:941-949.
39. Singh A., Garg V., Gupta S., Kulkarni S.K. Role of antioxidants in chronic fatigue syndrome in mice. Indian J Exp Biol 2002, 40:1240-1244.
40. Fernandez L., Romero M., Rincon J., Mosquera J. Increased expression of CD54, CD18, MHC class II and proliferanting cell nuclear antigen in acute puromycin aminonucleoside nephrosis. Nephron Exp Nephrol 2003, 94:e55-e65.
41. Chein C.T., Lee P.H., Chen C.F., Ma M.C., Lai M.K., Hsu S.M. De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol 2001, 12:973-992.
42. Moreno-Manzano V., Ishikawa Y., Lucio-Cazana J., Kitamura M. Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-alpha-induced apoptosis of rat mesangial cells. J Biol Chem 2000, 28:12684-12691.
43. Ruiz-Ortega M., Lorenzo O., Rupérez M. Role of the renin-angiotensin system in vascular diseases expanding the field. Hypertension 2001, 38:1382-1387.
44. Van de Kar L.D. Forebrain pathways mediating stress-induced renin secretion. Clin Exp Pharmacol Physiol 1996, 23:166-170.
45. Iglarz M., Touyz R.M., Viel E.C., Amiri F., Schiffrin E.L. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin angiotension system. Am J Hypertens 2004, 17:597-603.
46. Evans R.G., Fitzgerald S.M. Nitric oxide and superoxide in the renal medulla: a delicate balancing act. Curr Opin Nephrol Hypertens 2005, 14:9-15.
47. Nayak V., Patil P.A. Antidepressant activity of fosinopril, ramipril and losartan, but not of lisinopril in depressive paradigms of albino rats and mice. Indian J Exp Biol 2008, 46:180-184.
48. Tang R., Zhou Q.L., Ao X., Peng W.S., Veeraragoo P., Tang T.F. Fosinopril and losartan regulate klotho gene and nicotinamide adenine dinucleotide phosphate oxidase expression in kidneys of spontaneously hypertensive rats. Kidney Blood Press Res 2011, 34:350-357.
49. Heeba G.H. Angiotensin II receptor blocker, losartan, ameliorates gentamicin-induced oxidative stress and nephrotoxicity in rats. Pharmacology 2011, 87:232-240.
50. Fountoulakis K.N., Iacovides A., Gerasimou G., Fotiou F., Ioannidou C., Bascialla F., et al. The relationship of regional cerebral blood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:537-546.
51. Benabarre A., Vieta E., Martin F., Lomena F., Martinez-Aran A., Colom F., et al. Clinical value of 99mTc-HMPAO SPECT in depressed bipolar I patients. Psychiatry Res 2004, 132:285-289.
52. Ohgami H., Nagayama H., Akiyoshi J., Tsuchiyama K., Komaki S., Takaki H., et al. Contributing factors to changes of cerebral blood flow in major depressive disorder. J Affect Disord 2005, 87:57-63.
53. Perico C.A., Skaf C.R., Yamada A., Duran F., Buchpiguel C.A., Castro C.C., et al. Relationship between regional cerebral blood flow and separate symptom clusters of major depression: a single photon emission computed tomography study using statistical parametric mapping. Neurosci Lett 2005, 384:265-270.
54. Bondy B., Baghai T.C., Zill P., Schule C., Eser D., Deiml T., et al. Genetic variants in the angiotensin I-converting enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1094-1099.
55. Kazama K., Anrather J., Zhou P., Girouard H., Frys K., Milner T.A., et al. Angiotensin II impairs neurovascular coupling in neocortex through nadph oxidase-derived radicals. Circ Res 2004, 95:1019-1026.
56. Gard P.R., Mandy A., Sutcliffe M.A. Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression. Biol Psychiatry 1999, 45:1030-1034.
57. Gard P.R. Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression. Expert Opin Ther Targets 2004, 8:7-14.
58. Kumar P., Kalonia H., Kumar A. Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease. Behav Pharmacol 2010, 21:217-230.
59. Kumar P., Kalonia H., Kumar A. Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study. J Psychopharmacol Mar 19 2010.
60. Gaur V., Kumar A. Behavioral, biochemical and cellular correlates in the protective effect of sertraline against transient global ischemia induced behavioral despair: possible involvement of nitric oxide-cyclic guanosine monophosphate study pathway. Brain Res Bull 2010, 82:57-64.
61. Lin H., Decuypere E., Buyse J. Oxidative stress induced by corticosterone administration in broiler chickens (Gallus gallus domesticus) 2. Short-term effect. Comp Biochem Physiol B Biochem Mol Biol 2004, 139:745-751.